Snowball logo
logo
1734_logo

Sinphar Pharmaceutical Co Ltd

1734 β€’ TW
NT$31.85NT$0.00Β  (0%)
πŸ’‘ Click on a row in the table to make it appear on the graph
πŸ“Š Compare financials of multiple companies on the same chart
This feature is available with our premium plans. Upgrade to unlock the full potential of Snowball Analytics and be on top of your investments!
20212022202320242025TTM
Revenue
Total revenue
2,433.52,856.72,962.93,150.63,371.33,392.4
COGS
1,544.81,765.41,871.71,913.61,914.41,936.4
Gross Profit
888.71,091.31,091.21,2371,456.91,456
Operating Expenses & Income
Operating Income
(180.2)197.8286.1294416.9396.8
Total Operating Expenses
1,071.5893.5803.59431,0401,059.2
R&D Expenses
511.9272.2132.6151.4145.4156.1
Selling General & Admin Expenses
201.6213.1224.2248.5894.7262.3
Earnings from Continuing Operations
Interest Expense
(24.8)(27.81)(33.71)(36.77)(33.85)(32.06)
Interest Income
3.6835.77612.3116.8412.6113.25
Income Tax Expense
20.4380.87(51.07)21.8847.2566.44
Net Income
Net Income
(38.13)224.6375.2304.7365.8327.2
Supplemental
EBIT
(159.7)272.9339.4343.9435.4407.5
EBITDA
109.6539.6582.9601.2689.7661.3
In millions of TWD, except % and values per 1 share